Form 4: MPW SVP Acquires Performance-Based Equity
Executive Stock Grant
Medical Properties Trust's SVP of Operations, Rosa Handley Hooper, received 52,185 shares of common stock through grants, including performance-based awards tied to future total shareholder return.
Summary
- Rosa Handley Hooper, SVP of Operations at Medical Properties Trust Inc. (MPW), acquired a total of 52,185 shares of common stock on September 24, 2025.
- The acquisitions were grants at a price of $0.00 per share, indicating they are part of an equity compensation plan.
- Following these transactions, Ms. Hooper beneficially owns 400,743 shares of common stock.
- A grant of 36,765 shares will vest at the beginning of each calendar quarter, concluding on March 31, 2028.
- An additional grant of 15,420 shares is performance-based, issued under the Company's Amended and Restated 2019 Equity Incentive Plan.
- These performance shares are contingent on achieving specific Company Total Shareholder Return (TSR) hurdles over a three-year period ending April 14, 2028.
- TSR hurdles are set at 20% for 100% earning, 40% for 200% earning, and 60% for 300% earning, with linear interpolation for intermediate performance.
- Earned performance shares will vest in equal quarterly installments over one year following the earning date, with full vesting upon the Compensation Committee's final determination, subject to continued employment.
Sentiment
Score: 7
Explanation: The acquisition of shares by a senior executive, particularly through performance-based grants, generally indicates alignment of management's interests with shareholders and incentivizes future performance. While not a direct cash investment, it strengthens the executive's stake in the company's success.
Positives
- The acquisition of shares by a senior executive increases insider ownership, aligning management's financial interests with those of shareholders.
- The inclusion of performance-based awards tied to Total Shareholder Return (TSR) incentivizes management to focus on long-term shareholder value creation.
Negatives
- The shares were acquired at a price of $0.00, meaning there was no direct cash investment by the insider in these specific transactions.
Risks
- The actual number of performance-based shares earned is contingent on Medical Properties Trust achieving specific Total Shareholder Return (TSR) hurdles, which are not guaranteed.
- Vesting of both time-based and performance-based shares is subject to the grantee's continued employment through the respective vesting dates.
Future Outlook
The performance-based equity awards are structured to incentivize the company's Total Shareholder Return (TSR) growth over a three-year period ending April 14, 2028, with the number of shares earned directly tied to achieving specific TSR hurdles.
Management Comments
- The shares were granted under the Medical Properties Trust, Inc. Amended and Restated 2019 Equity Incentive Plan.
Industry Context
Equity grants and performance-based compensation are standard practices across publicly traded companies, including those in the REIT sector, to align executive incentives with long-term shareholder value creation and retention.
Comparison to Industry Standards
- NA
Stakeholder Impact
- Shareholders: Potential for increased long-term value if the Total Shareholder Return (TSR) hurdles are met, driven by management's incentivized performance.
- Employees (specifically the reporting person): Increased equity stake and incentive compensation, fostering greater alignment with company performance.
Next Steps
- Monitor the company's Total Shareholder Return (TSR) performance against the specified hurdles for the performance-based awards.
- Observe the future vesting of the granted shares according to their respective schedules.
Key Dates
| Date | Description |
|---|---|
| 09/24/2025 | Date of transaction for the acquisition of common stock. |
| 09/26/2025 | Date the Form 4 was signed by power of attorney. |
| 03/31/2028 | End date for the vesting period of 36,765 shares. |
| 04/14/2028 | End of the three-year performance period for the 15,420 performance-based shares. |
Recommendation
holdThis Form 4 filing details routine executive compensation through equity grants, including performance-based awards. While it indicates alignment of management incentives with shareholder interests, it does not provide new fundamental information about the company's operations or financial health that would warrant a change in a broader investment recommendation. It is a standard disclosure of insider ownership changes.
Keywords
Medical Properties Trust, MPW, Insider Trading, Form 4, Equity Grant, Performance Shares, Executive Compensation, Total Shareholder Return, SVP of Operations
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.